Pulse Electromagnetic Field Therapy Devices Market Size
The Pulse Electromagnetic Field Therapy Devices Market reached US$ 285.52 million in 2025 and is expected to reach US$ 452.78 million by 2033, growing at a CAGR of 8.43% during the forecast period 2026-2033.
Market Scope
| Metrics | Details |
| Market CAGR | 8.43% |
| Segments Covered | By Power, By Application, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Pulse Electromagnetic Field Therapy Devices Market Trends and Dynamics
Pulsed electromagnetic field therapy to treat injuries and pain is expected to increase as the risk of fractures from falls and accidents increases, as does the number of sports injury cases. A growing focus on advanced product development, such as small devices and remote operation by integrating with mobile phone characteristics, is expected to drive market expansion significantly throughout the forecast period.
The increase in prevalance of road accidents and sports injuries will drive the market growth
Delay union and nonunion fractures and serious spinal injuries are common after trauma and car accidents. These injuries necessitate immediate surgery. When treating fresh fractures, fracture nonunion, delayed unions, and failed spinal fusions, these therapy devices are employed to aid in the healing process of these bones. Furthermore, as the number of people with osteoporosis rises, the market for pulsed electromagnetic field therapy equipment increases.
The majority of people today suffer from pain due to fractures from accidents, sports injuries, falls from a certain height, and indications such as arthritis, joint pain, and knee pain. According to recent WHO statistics, nearly 1.3 million people die each year due to traffic accidents. Most road fatalities (93 per cent) occur in low- and middle-income countries. Non-fatal injuries affect between 20 million and 50 million people, with many becoming disabled due to their injuries.
According to a study conducted by the Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures each year, resulting in an osteoporosis fracture every three seconds.
The pulse electromagnetic field therapy devices are non-invasive and safe. These devices have no discernible adverse effects. PEMF therapy also provides a new treatment option for various musculoskeletal disorders. These devices have been approved by the US Food and Drug Administration to treat non-union fractures. The devices are also used to treat edema, discomfort, plantar fasciitis, and post-operative osteoporosis, among other things.
PEMF therapy devices have several advantages, including reducing acute and chronic pain associated with various connective tissues, such as inflammation control, edema, cartilage injury, ligaments, tendon, and bone. As a result of these advantages, the pulsed electromagnetic field therapy devices market is expected to rise significantly in the coming years.This contributes to the growth of the global pulse electromagnetic field therapy devices market.
Lack of infrastructure is likely to hamper the market growth
Due to the scarcity of suitable infrastructure required to use these devices, there is a high risk of device failure. In the absence of infrastructure, there is a lack of knowledge and resources required to operate pulse electromagnetic field therapy devices. Instead of treating the pain, defective devices can exacerbate it, threatening the growth of the pulse electromagnetic magnetic fields therapy devices market in the coming years
Pulse Electromagnetic Field Therapy Devices Market Major Players
The pulse electromagnetic field therapy devices market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Bedfont Scientific, Orthofix Holdings, I- Tech Medical Division, OSKA, Medithera, Niu Desai, Nuage Health, Oxford Medical Instruments Health, BEMER, LLC , HealthyLine, Sedona Wellness , Pulsed Energy Technologies LLC.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the blood and blood products market globally.
Orthofix Holdings
Overview: Orthofix Holdings is a medical device company that provides healthcare providers with orthopedic and spine solutions. The company is divided into two segments: global spine, which includes bone growth and healing therapies, spinal implants, and regenerative tissue products, and global extremities, which offers products and solutions for non-spinal bone conditions. The global spine segment in the US accounts for most of the company's sales. Orthofix sells its products in North America, Europe, and several other countries worldwide. Hospitals, physicians, other healthcare providers, and patients can all benefit from the company's solutions.
Product Portfolio:
PhysioStim: The PhysioStim devices are available in various models and are anatomically designed to fit the patient's body. Nonunion fractures of the arm, hand, wrist, clavicle, shoulder, hip, thigh, lower leg, ankle, or foot have specific applications. The devices are designed to be worn over clothing, casts, and internal and external surgical fixation devices.
Recent Industry Developments
- March 2026 – Shift toward wearable, home-use PEMF devices accelerates adoption
The market is moving beyond clinical devices toward portable mats, wearables, and home therapy systems, driven by consumer wellness trends and demand for non-invasive, drug-free treatments for chronic pain and inflammation. - March 2026 – Integration of PEMF into multi-therapy wellness systems gains traction
PEMF technology is increasingly being combined with infrared therapy, red-light therapy, vibration therapy, and biofeedback systems, creating hybrid wellness platforms used in recovery clinics and home wellness devices. - February 2026 – Orthofix Holdings and Medithera strengthen clinical-grade PEMF applications
Medical device companies are focusing on orthopedic and post-surgical bone healing applications, where PEMF therapy is clinically used to support fracture repair and musculoskeletal recovery under physician supervision. - February 2026 – Growing acceptance in sports medicine and rehabilitation centers
Sports recovery clinics are increasingly adopting PEMF systems to support muscle recovery, inflammation reduction, and injury rehabilitation, particularly among professional athletes and physiotherapy centers. - January 2026 – Rising consumer adoption driven by “biohacking” and wellness trends
PEMF devices are gaining popularity in the wellness and biohacking community, with home-use mats and systems marketed for sleep improvement, stress reduction, and cellular energy support, though clinical validation remains mixed. - January 2026 – Increasing clinical validation for bone growth and pain management applications
PEMF therapy continues to be supported in medical literature for bone healing, pain reduction, and inflammation control, with FDA-cleared devices used in specific orthopedic indications.

























































